(Q44298630)

English

Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation (English)

1 reference

Europe PubMed Central

1 December 2017

Peter P Nawroth

6

object named as

P P Nawroth

1 reference

Europe PubMed Central

1 December 2017

Angelika Bierhaus

4

object named as

A Bierhaus

1 reference

Europe PubMed Central

1 December 2017

author name string

M Brune

1

1 reference

Europe PubMed Central

1 December 2017

M Müller

2

1 reference

Europe PubMed Central

1 December 2017

G Melino

3

1 reference

Europe PubMed Central

1 December 2017

T Schilling

5

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

30 April 2012

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

32

1 reference

Europe PubMed Central

1 December 2017

11

1 reference

Europe PubMed Central

1 December 2017

1460-1468

1 reference

Europe PubMed Central

1 December 2017

https://scigraph.springernature.com/pub.10.1038/onc.2012.150

0 references

Understanding RAGE, the receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Nuclear factor-kappaB in cancer development and progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Regulation of osteoclast function and bone mass by RAGE.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Osteoporosis in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Diabetes induced changes in rat mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

RAGE signaling sustains inflammation and promotes tumor development

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

21 January 2018

Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

RAGE regulates autophagy and apoptosis following oxidative injury

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE)

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

Cell apoptosis of taste buds in circumvallate papillae in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

Mortality after hip fracture in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.150

31 March 2020

Identifiers

10.1038/ONC.2012.150

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44298630&oldid=2109267214"